CAJ | 학술논문

目的:评价玻璃体腔注射曲安奈德治疗视网膜静脉阻塞合并黄斑水肿的疗效及并发症.方法:患者30例30眼玻璃体腔注射曲安奈德4mg治疗视网膜静脉阻塞合并黄斑水肿,观察治疗前、后的最佳矫正视力、眼压、裂隙灯显微镜检查、眼底荧光血管造影和光学相干断层扫描的变化,采用SPSS 12.0软件进行统计学分析.结果:所有患者手术后视力均显著提高,平均黄斑中心凹厚度(CMT)显著减少.病程、年龄、注射前CMT及视网膜静脉阻塞的类型和视力预后无相关性,注射前视力与注射后末次视力呈正相关.结论:玻璃体腔注射曲安奈德治疗视网膜静脉阻塞合并黄斑水肿简单、安全、易操作,短期内可以迅速减轻黄斑水肿,最终的视力预后取决于治疗前的视力,部分患者在注射后3～6mo可能复发.
목적:평개파리체강주사곡안내덕치료시망막정맥조새합병황반수종적료효급병발증.방법:환자30례30안파리체강주사곡안내덕4mg치료시망막정맥조새합병황반수종,관찰치료전、후적최가교정시력、안압、렬극등현미경검사、안저형광혈관조영화광학상간단층소묘적변화,채용SPSS 12.0연건진행통계학분석.결과:소유환자수술후시력균현저제고,평균황반중심요후도(CMT)현저감소.병정、년령、주사전CMT급시망막정맥조새적류형화시력예후무상관성,주사전시력여주사후말차시력정정상관.결론:파리체강주사곡안내덕치료시망막정맥조새합병황반수종간단、안전、역조작,단기내가이신속감경황반수종,최종적시력예후취결우치료전적시력,부분환자재주사후3～6mo가능복발.
·AIM: To evaluate the efficacy and safety of intravitreal triamcinolone acetonide(TA) as treatment for macular edema associated with retinal vein occlusion(RVO).·METHODS: The study group consisting 30 patients (30 eyes) with RVO combined with macular edema received intravitreal 4mg TA. Changes in best-corrected visual acuity (BCVA), intraocular pressure(IOP), examination with slit-lamp microscope, fluorescein angiography and optical coherence tomography(OCT) were observed during the follow-up. Statistical analysis was conducted with SPSS 12.0 software.·RESULTS: The visual acuity(VA) of all patients was significantly improved and the central macular thickness (CMT) was significantly relieved. There was no correlation between course, age, CMT before injection and the type of RVO. There was positive correlation between visual acuity before injection and after injection.·CONCLUSION: Intravitreal injection of TA is an easy-operated and safe therapy. After injection, macular edema can be rapidly relieved. VA at baseline is the predictor for the prognosis of VA. Some patients experience recurrence of macular edema between 3 to 6 months after injection.